000			01196nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aMultimodality Treatments in Metastatic Gastric Cancer
546			_aEnglish[eng]
650			_aadvanced gastric cancer||precision medicine||new drug development||gastro-oesophageal cancer||mutational concordance||exome sequencing||formalin fixed paraffin embedded||biomarkers||gastric cancer||metastatic||body composition||sarcopenia||visceral fat area||subcutaneous fat area||outcome||toxicity||liver metastasis||conversion surgery||hepatectomy||stage iv gastric cancer||immune checkpoint inhibitors||Epstein Barr Virus||tumor mutational burden||microsatellite instability||predictive biomarkers||CAR T cell therapy||vaccines||nutritional status||metastatic gastric cancer||target therapy||bone flare||stage IV||treatment||RANK-L||liquid biopsy||circulating tumor cell||cfDNA||ctDNA||epithelial–mesenchymal transition||resistance to treatment||HER2-inhibition||VEGFR-inhibition||immunotherapy||response monitoring||n/a
700			_aPetrillo, Angelica
856			_uhttps://mdpi.com/books/pdfview/book/4696
942			_cEB
999			_c23412 _d23412